Tetsushi Taguchi

Dr. Tetsushi Taguchi


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Biomaterials
Verified
Journal Article
Closed access
TTTetsushi Taguchi
Tetsushi Taguchi
LXLiming Xu
Liming Xu
HKHisatoshi Kobayashi
Hisatoshi Kobayashi
ATAkiyoshi Taniguchi
Akiyoshi Taniguchi
KKKazunori Kataoka
Kazunori Kataoka
JTJunzo Tanaka
Junzo Tanaka

1 November 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
ANAkihiro Nishiguchi
Akihiro Nishiguchi
YKYukari Kurihara
Yukari Kurihara
TTTetsushi Taguchi
Tetsushi Taguchi

15 March 2017 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
YMY. Mizuno
Y. Mizuno
RMR. Mizuta
R. Mizuta
MHM. Hashizume
M. Hashizume
TTTetsushi Taguchi
Tetsushi Taguchi
The aim of this study was the development of an innovative biocompatible sealant composed of Alaska pollock-derived gelatin partially modified with a dodecyl group (C12-ApGltn) and a poly(ethylene glycol)-based crosslinker, pentaerythritol poly(ethylene glycol) ether tetrasuccinimidyl glutarate. The burst strength of the developed sealants was measured using porcine aorta and rat lungs. The maximum burst strength of a C12-ApGltn-based sealant against the porcine aorta was 4-fold higher than that of an original ApGltn (Org-ApGltn)-based sealant. No significant increase in the burst strength was observed between C12-ApGltn-based sealants with 4.2 and 8.9 mol% modification ratios. From histological observation after burst strength measurement, tissue tearing was observed when a C12-ApGltn-based sealant was applied. In contrast, the Org-ApGltn-based sealant was peeled away from the aorta surface due to cohesion failure. Similar to the porcine aorta, the burst strength of C12-ApGltn-based sealants applied on a rat lung defect was 3-fold higher than that of an Org-ApGltn-based sealant. The curing time of the C12-ApGltn-based sealant measured by a simple mixing method was shorter (2.6 ± 0.1 s) than that of the Org-ApGltn-based sealant (4.1 ± 0.3 s). The swelling ratio of the C12-ApGltn-based sealant (23.7 ± 3.1) was significantly lower than that of the Org-ApGltn-based sealant (32.3 ± 1.1). The C12-ApGltn-based sealant was completely degraded within 28 days after implantation in the backs of rats without a severe inflammation reaction. However, the Org-ApGltn-based sealant disappeared within 14 days. These results indicated that hydrophobically-modified ApGltn has an effective sealing effect on moist tissues and biocompatibility in vivo.

15 July 2019 in Small
Verified
Journal Article
Closed access
PDF file
ANAkihiro Nishiguchi
Akihiro Nishiguchi
FSFumisato Sasaki
Fumisato Sasaki
HMHidehito Maeda
Hidehito Maeda
MKMasayuki Kabayama
Masayuki Kabayama
AIAkio Ido
Akio Ido
TTTetsushi Taguchi
Tetsushi Taguchi

30 April 2002 in Journal of Biomedical Materials Research
Verified
Journal Article
Closed access
PDF file
TTTetsushi Taguchi
Tetsushi Taguchi
TIToshiyuki Ikoma
Toshiyuki Ikoma
JTJunzo Tanaka
Junzo Tanaka

10 January 2020 in ACS Omega
Verified
Journal Article
Open access
XCXi Chen
Xi Chen
TTTetsushi Taguchi
Tetsushi Taguchi
Hydrophobically modified poly(vinyl alcohol) (hm-PVA) films with various alkyl chain lengths were prepared. Their surface/mechanical properties, cytocompatibility, and porcine skin adhesion strength were evaluated. hm-PVAs had 10 °C higher glass transition temperature than poly(vinyl alcohol) (PVA) (33.4 ± 2.5 °C). The water contact angle of the hm-PVA films increased with alkyl chain length and/or hydrophobic group modification ratio. The tensile strength of the hm-PVA films decreased with increasing alkyl chain length and/or hydrophobic group modification ratio. hm-PVA with short chain lengths (4 mol % propanal-modified PVA; 4C3-PVA) had low cytotoxicity compared with long alkyl chain length hm-PVAs (4 mol % hexanal and nonanal-modified PVA; 4C6-PVA and 4C9-PVA). The 4C3-PVA film had the highest porcine skin adhesion strength. Thus, the 4C3-PVA film is promising as an adhesive for wearable medical devices.